Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Condylomata Acuminata × Hepatitis B Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Whooping Cough 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Pneumococcal Infections 1 Neoplasm Metastasis 1 Measles 1 Hepatitis B 1 HIV Infections 1 Condylomata Acuminata 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14 Vaccines, Synthetic 10 Papillomavirus Vaccines 6 Vaccines 5 Imiquimod 4 Trichloroacetic Acid 3 Gels 3 green tea extract polyphenone E 2 Podophyllin 2 Human Papillomavirus Recombinant Vaccine nonavalent 2 Ethanol 2 Duration of Therapy 2 Cantharidin 2 ranpirnase 1 polyphenon E 1 nanocurcumin 1 hecolin 1 berdazimer sodium 1 Zinc 1 Viusid 1 Vaccination 1 VP-102 1 Therapies, Investigational 1 Tea 1 PRA1 protein, Candida albicans 1 Omiganan 1 Ointments 1 Measles-Mumps-Rubella Vaccine 1 Lasers, Gas 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02750202 2026-01-23

TheraVACCS

University of Pretoria

Phase 3 Completed

52 enrolled 34 charts

Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon ⚡